Dr Paul Newbold is a Project Co-ordination Director in Early Clinical development at AstraZeneca. He has been at AstraZeneca for nearly 14 years during which time he has worked in both Preclinical and Clinical research. Prior to this he worked at Roche, Welwyn Garden City, before going on and doing a PhD at King’s College London and a Postdoctoral period at St. Bartholomew’s Medical College, joining Astra in 1995. His main area of focus in recent years has been biomarker development for early efficacy studies in respiratory disease.